探索澳大利亚住院养老院心理药物使用的质量改善过程:一项定性研究
Shakti Shrestha1, Amanda J Cross2, Michelle Steeper3
1School of Pharmacy and Pharmaceutical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, Australia.
Journal of pharmaceutical policy and practice
|September 25, 2025
概括
澳大利亚的养老院正在通过新法规推动的质量系统改进来改善心理药物使用. 有机会更好地利用临床数据,促进跨学科合作,以改善患者护理.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 最近澳大利亚的监管转变强调了在住院老年护理中适当使用精神药物药物的系统级策略.
- 这项研究调查了这些设施内心理药物管理的质量改善 (QI) 过程.
研究的目的:
- 探索澳大利亚住院养老机构在心理药物使用方面实施的质量改进过程.
- 为了确定促进者和障碍物,以有效的心理药物管理在这个环境中.
主要方法:
- 这是一项定性研究,涉及深入的半结构面试,与澳大利亚四个州的33个主要利益相关者进行了深入的半结构面试.
- 参与者包括来自大都会和地区设施的护士,相关卫生专业人员,医疗从业者,住院人员和护理人员.
- 专题分析,在学习健康系统框架内采用诱导和演方法,用于分析字面采访成绩单.
主要成果:
- 监管变化正在积极推动对心理药物管理的组织政策和程序的更新.
- 老年护理组织正在积极提高其质量改进系统,并纳入成功的医疗保健QI的元素.
- 关键的挑战包括平衡符合质量改进目标,并协调多学科专业的努力.
结论:
- 最近的政策和基础设施变化为老年护理中心理药物使用提供了更好的监督.
- 显而易见的是,在心理药物管理方面,正在转向个人和系统层面的方法.
- 提高利用当地临床数据的能力和建立强大的跨学科团队对于未来的改进至关重要.
相关概念视频
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K
01:15Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
01:28Drug Therapy
245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
245
01:26Psychosis: Goals of Pharmacotherapy
474
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
474
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228